drugset
Drugs / botulinum neurotoxin A
last change May 2026 re-read 3 minutes ago

botulinum neurotoxin A

also known as BoNT-A · Botox · onabotulinumtoxin A
Developed for
cerebral palsy
Investigated by
Fondation Lenval · Haukeland University Hospital · Mazowieckie Centrum Neuropsychiatrii, Warszawa · Norwegian University of Science and Technology · Oslo University Hospital · St. Olavs Hospital
+2 more · The Hospital of Vestfold · University Hospital of North Norway

Trials 1

today NCT02546999 · Ph 4
201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 4 NCT02546999 Sep 2015 → Oct 2021 cerebral palsy St. Olavs Hospital Completed Missed primary

Press releases naming this drug 1 release

DateIssuerRelease
2026-05-19 Ipsen Ipsen announces late-breaking data from first head-to-head study comparing Dysport® and Botox® in adults with upper limb spasticity ipsen.com ↗

Evidence & citations 5 cited values

Every value below carries the sentence it was read from. 2 sources stand behind the page.

FieldValueCited text
Known as botulinum neurotoxin A “AIM: To assess the effect of single botulinum neurotoxin A (BoNT-A) injections into the calf muscles on the gross energy cost of walking in children with cerebral palsy (CP)...” PMID 39058740 ↗ Jul 2024
Known as BoNT-A “AIM: To assess the effect of single botulinum neurotoxin A (BoNT-A) injections into the calf muscles on the gross energy cost of walking in children with cerebral palsy (CP)...” PMID 39058740 ↗ Jul 2024
Known as Botox “Botox® (onabotulinumtoxin A),injections in the calf muscles.” NCT02546999 ↗
Known as onabotulinumtoxin A “Botox® (onabotulinumtoxin A),injections in the calf muscles.” NCT02546999 ↗
Route Intramuscular “The route of administration is intramuscular injection.” NCT02546999 ↗